Surge in Options Trading: Biogen, Gilead, and Procter & Gamble Stand Out

Biogen Inc. (Symbol: BIIB) is seeing a flurry of options trading activity today, with a total of 11,054 contracts executed. This volume translates to around 1.1 million underlying shares, which is about 82.3% of BIIB’s average daily trading volume of 1.3 million shares over the past month. The $130 strike call option, set to expire on February 21, 2025, has particularly caught traders’ attention, boasting 779 contracts traded so far, equivalent to approximately 77,900 underlying shares. The chart below displays BIIB’s trading history over the last year, highlighting the $130 strike in orange:

Gilead Sciences Inc. (Symbol: GILD) has also experienced notable options trading, with a volume of 50,816 contracts. This number corresponds to about 5.1 million underlying shares and approximately 69.6% of GILD’s average daily trading volume of 7.3 million shares over the last month. The $102 strike call option expiring on February 21, 2025, led the trading today with 6,969 contracts executed, representing around 696,900 underlying shares. The following chart illustrates GILD’s trading activity over the previous twelve months, with the $102 strike highlighted in orange:

Procter & Gamble Company (Symbol: PG) is also making its mark, showing a trading volume of 38,469 contracts today. This amount represents approximately 3.8 million underlying shares, accounting for 53.4% of PG’s average daily trading volume of 7.2 million shares over the past month. The $172.50 strike call option, expiring on February 14, 2025, is notable, with 12,510 contracts traded, which equates to about 1.3 million underlying shares of PG. Below is a chart that depicts PG’s trading patterns over the last year, with the $172.50 strike marked in orange:

For further insights on the various available expirations for options of BIIB, GILD, or PG, please visit StockOptionsChannel.com.

Today’s Most Active Call & Put Options of the S&P 500 »

Also see:

• Low PE Ratios
• HYGV Videos
• Top Ten Hedge Funds Holding PEZ

The views and opinions expressed herein are those of the author and do not necessarily reflect those of Nasdaq, Inc.